385 related articles for article (PubMed ID: 32289357)
1. Recombinant expression of nanobodies and nanobody-derived immunoreagents.
de Marco A
Protein Expr Purif; 2020 Aug; 172():105645. PubMed ID: 32289357
[TBL] [Abstract][Full Text] [Related]
2. Engineering and characterization of GFP-targeting nanobody: Expression, purification, and post-translational modification analysis.
Weng D; Yang L; Xie Y
Protein Expr Purif; 2024 Sep; 221():106501. PubMed ID: 38782081
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic Production of Nanobodies and Nanobody-Based Reagents by Co-Expression of Sulfhydryl Oxidase and DsbC Isomerase.
de Marco A
Methods Mol Biol; 2022; 2446():145-157. PubMed ID: 35157272
[TBL] [Abstract][Full Text] [Related]
4. Purification-independent immunoreagents obtained by displaying nanobodies on bacteria surface.
Oloketuyi S; Dilkaute C; Mazzega E; Jose J; de Marco A
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4443-4453. PubMed ID: 30989251
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of fusion tags used to functionalize recombinant antibodies.
Veggiani G; Giabbai B; Semrau MS; Medagli B; Riccio V; Bajc G; Storici P; de Marco A
Protein Expr Purif; 2020 Feb; 166():105505. PubMed ID: 31563543
[TBL] [Abstract][Full Text] [Related]
6. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
Front Immunol; 2021; 12():838082. PubMed ID: 35116045
[TBL] [Abstract][Full Text] [Related]
7. A novel silk fibroin protein-based fusion system for enhancing the expression of nanobodies in Escherichia coli.
Yu J; Guo Y; Gu Y; Fan X; Li F; Song H; Nian R; Liu W
Appl Microbiol Biotechnol; 2022 Mar; 106(5-6):1967-1977. PubMed ID: 35243528
[TBL] [Abstract][Full Text] [Related]
8. Production and Application of Nanobodies for Membrane Protein Structural Biology.
Brunner JD; Schenck S
Methods Mol Biol; 2020; 2127():167-184. PubMed ID: 32112322
[TBL] [Abstract][Full Text] [Related]
9. Secretory production of a camelid single-domain antibody (VHH, nanobody) by the Serratia marcescens Lip system in Escherichia coli.
Asada T; Takagi D; Nakai M; Abe S; Yuasa K
Biochem Biophys Res Commun; 2021 Apr; 549():105-112. PubMed ID: 33667707
[TBL] [Abstract][Full Text] [Related]
10. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
[TBL] [Abstract][Full Text] [Related]
11. Improving the yield of recalcitrant Nanobodies® by simple modifications to the standard protocol.
Kariuki CK; Magez S
Protein Expr Purif; 2021 Sep; 185():105906. PubMed ID: 33991675
[TBL] [Abstract][Full Text] [Related]
12. Generation of mWasabi fluorescent protein-binding nanobodies.
Li S; Shan H; Wang T; Zheng X; Shi M; Chen B; Lu H; Zhang Y; Zhao S; Hua Z
Anal Biochem; 2020 Nov; 608():113875. PubMed ID: 32739350
[TBL] [Abstract][Full Text] [Related]
13. CDR1 Composition Can Affect Nanobody Recombinant Expression Yields.
Orlando M; Fortuna S; Oloketuyi S; Bajc G; Goldenzweig A; de Marco A
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572576
[TBL] [Abstract][Full Text] [Related]
14. Generation of Nanobodies against SlyD and development of tools to eliminate this bacterial contaminant from recombinant proteins.
Hu Y; Romão E; Vertommen D; Vincke C; Morales-Yánez F; Gutiérrez C; Liu C; Muyldermans S
Protein Expr Purif; 2017 Sep; 137():64-76. PubMed ID: 28668496
[TBL] [Abstract][Full Text] [Related]
15. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
Li S; Meng X; Li R; Huang B; Wang X
BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic versus periplasmic expression of site-specifically and bioorthogonally functionalized nanobodies using expressed protein ligation.
Billen B; Vincke C; Hansen R; Devoogdt N; Muyldermans S; Adriaensens P; Guedens W
Protein Expr Purif; 2017 May; 133():25-34. PubMed ID: 28238765
[TBL] [Abstract][Full Text] [Related]
17. An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.
Ta DT; Redeker ES; Billen B; Reekmans G; Sikulu J; Noben JP; Guedens W; Adriaensens P
Protein Eng Des Sel; 2015 Oct; 28(10):351-63. PubMed ID: 26243885
[TBL] [Abstract][Full Text] [Related]
18. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.
Baghban R; Gargari SL; Rajabibazl M; Nazarian S; Bakherad H
Biotechnol Appl Biochem; 2016; 63(2):200-5. PubMed ID: 24673401
[TBL] [Abstract][Full Text] [Related]
19. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
Ferrari D; Garrapa V; Locatelli M; Bolchi A
Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
[TBL] [Abstract][Full Text] [Related]
20. In Silico Investigation of Signal Peptide Sequences to Enhance Secretion of CD44 Nanobodies Expressed in Escherichia coli.
Kavousipour S; Mohammadi S; Eftekhar E; Barazesh M; Morowvat MH
Curr Pharm Biotechnol; 2021; 22(9):1192-1205. PubMed ID: 33045964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
